Evidence map›Paper›PMID 27883292›Full record

ArticlePharmacogenomics2016

IL1A rs1800587 associates with chronic noncrisis pain in sickle cell disease.

Xiaoyu Hu, Ellie H Jhun, Yingwei Yao, Ying He, Robert E Molokie, Diana J Wilkie, Zaijie J Wang

Abstract read
In one paragraph

Article in Pharmacogenomics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Inflammation in sickle cell disease.Clinical hemorheology and microcirculation · 2018
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Xiaoyu HuDepartment of Biopharmaceutical Sciences, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA.
Ellie H JhunDepartment of Biopharmaceutical Sciences, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA.
Yingwei YaoDepartment of Biobehavioral Health Science, University of Illinois at Chicago College of Nursing, Chicago, IL, USA.
Ying HeDepartment of Biopharmaceutical Sciences, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA.
Robert E MolokieDepartment of Biopharmaceutical Sciences, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA.
Diana J WilkieDepartment of Biobehavioral Health Science, University of Illinois at Chicago College of Nursing, Chicago, IL, USA.
Zaijie J WangDepartment of Biopharmaceutical Sciences, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA.
University of Illinois Chicago · USFlorida College · US

Funding

Improving HbF induction by inhibiting epigenetic target enzymesU01HL117658 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ENGEL, JAMES DOUGLAS, LAVELLE, DONALD · 2013 to 2017
$8.3M
Multidisciplinary Oral Science TrainingT32DE018381 · NIDCR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI COOPER, LYNDON F · 2008 to 2019
$3.6M
HL-Phenotypic Characterization of Chronic Pain in Adults with Sickle Cell DiseaseR01HL124945 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MOLOKIE, ROBERT E, WANG, ZAIJIE JIM · 2014 to 2017
$3.2M
Computerized PAINRelievelt for Adult Sickle Cell DiseaseR01HL078536 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI WILKIE, DIANA J · 2006 to 2009
$3.1M
Protein kinase mechanisms for chronic pain in sickle cell diseaseR01HL098141 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI WANG, ZAIJIE JIM · 2009 to 2017
$2.6M
NHLBI NIH HHS R01 HL078536NHLBI NIH HHS R01 HL098141NHLBI NIH HHS R01 HL124945NHLBI NIH HHS U01 HL117658NIDCR NIH HHS T32 DE018381
6 · The paper itself

Abstract

aimPain is prevalent in sickle cell disease (SCD) patients who display great heterogeneity in pain severity and frequency. Hypothesizing that inflammatory factors are involved in the pathogenesis of SCD pain, we focused on the IL1A C/T polymorphism rs1800587 that is an SNP located in a cis-transcriptional regulatory region.

methodsWe genotyped IL1A rs1800587 and performed association studies with phenotype data obtained by a multidimensional pain assessment tool using the PAINReportIt

resultsEach T allele was associated with a 3.9 increase in composite pain index score (p = 0.04) as determined by multiple linear regression.

conclusionIL1A rs1800587 may influence chronic pain in SCD.

Indexed as

Polymorphism, Single NucleotideAdolescentAdultAgedAnemia, Sickle CellChronic PainFemaleHumansInterleukin-1alphaMaleMiddle AgedNecrosisIL1A protein, humanInterleukin-1alphachronicinflammationinterleukinpainpain crisispolymorphismpromotersickle celltranscription

Identifiers

PMID27883292
PMCPMC5220521
OpenAlexW2549663004

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.